Kammoun T, Prévot E, Serrand C, Perolat R, de Forges H, Houédé N, Beregi J-P, Frandon J. Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions. Cancers. 2022; 14(21):5432. https://doi.org/10.3390/cancers14215432
Summary: The aim of this retrospective study was to assess the feasibility of the IceCure’s single-probe liquid nitrogen system for tumor lesions of various sizes and locations, and to evaluate the safety of cryoablation with this technique.
Percutaneous liquid nitrogen cryotherapy used on kidney, bone, liver, lung, and soft tissue tumors is feasible, producing ablation zones of around 35 mm (long axis) with the use of 10G cryoprobes and 25 mm (long axis) with 13G probes, at around 20 min of freezing. The technique was safe, with no complications reported.
***Full article may require purchase***